Ibuprofen/famotidine

Ibuprofen/famotidine, sold under the brand name Duexis, is a fixed-dose combination medication used for the treatment of rheumatoid arthritis and osteoarthritis.^[1] It contains ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) and famotidine, a histamine H2-receptor antagonist.^[1]

Ibuprofen/famotidine

Combination of
Ibuprofen	Nonsteroidal anti-inflammatory drug (NSAID)
Famotidine	H2 antagonist
Clinical data
Trade names	Duexis
Other names	HZT-501
AHFS/Drugs.com	Micromedex Detailed Consumer Information
License data	US DailyMed: Ibuprofen and famotidine
Routes of administration	By mouth
ATC code	M01AE51 (WHO)
Legal status
Legal status	US: ℞-only[1]
Identifiers
CAS Number	1011231-26-7
KEGG	D11575

Ibuprofen/famotidine is available as a generic medication.^[2]

References

1. "Duexis- ibuprofen and famotidine tablet, coated". DailyMed. Retrieved 6 August 2021.
2. "Generic Duexis Availability". Drugs.com. 9 March 2023. Retrieved 17 March 2023.

Further reading

• Bello AE (October 2012). "Duexis (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug". Therapeutic Advances in Musculoskeletal Disease. 4 (5): 327–39. doi:10.1177/1759720X12444710. PMC 3458616. PMID 23024710.
• Deeks ED (September 2013). "Fixed-dose ibuprofen/famotidine: a review of its use to reduce the risk of gastric and duodenal ulcers in patients requiring NSAID therapy". Clin Drug Investig. 33 (9): 689–97. doi:10.1007/s40261-013-0113-x. PMID 23881568. S2CID 24972423.

External links

• "Famotidine mixture with ibuprofen". Drug Information Portal. U.S. National Library of Medicine.